Literature DB >> 1429208

Maternal transmission of HTLV-1 other than through breast milk: discrepancy between the polymerase chain reaction positivity of cord blood samples for HTLV-1 and the subsequent seropositivity of individuals.

K Kawase1, S Katamine, R Moriuchi, T Miyamoto, K Kubota, H Igarashi, H Doi, Y Tsuji, T Yamabe, S Hino.   

Abstract

We used a nested polymerase chain reaction (PCR) to diagnose HTLV-1 carriers. The DNA isolated from the nuclear extract obtained from frozen whole blood was found appropriate for PCR study both qualitatively and quantitatively. The use of freshly frozen whole blood made the field work much easier, and the use of a nuclear extraction procedure allowed DNA isolation in just 4 microcentrifuge tubes. We could not attain sufficient sensitivity to detect a single molecule with single-step PCR, but nested PCR was confirmed to detect a single molecule/reaction. All samples of the seropositive group including 94 blood donors, 66 mothers, and 13 children were positive in the nested PCR, while none of the seronegative group, including 198 blood donors and 285 children, was positive. Although 18/717 (2.5%) cord blood samples obtained from babies born to carrier mothers were PCR-positive, none of 5 formula-fed children tested who had been PCR-positive in the cord blood gave evidence of infection later on. Furthermore, all of 4 seropositive infected children who were formula-fed had been PCR-negative in their cord blood. The results are not consistent with intrauterine infection, but suggest the presence of a perinatal or postnatal infection route other than through breast milk.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1429208      PMCID: PMC5918983          DOI: 10.1111/j.1349-7006.1992.tb02009.x

Source DB:  PubMed          Journal:  Jpn J Cancer Res        ISSN: 0910-5050


human T‐lymphotropic virus type 1 ATL Prevention Program N,N′‐1,2‐ethanediylbis[N‐(carboxymethyl)glycine] ethidium bromide immunoblot immunofluorescence test months gelatin particle agglutination test polymerase chain reaction platelet‐derived growth factor ribonuclease white blood cells.
  43 in total

1.  Lack of viral latency of human T-cell lymphotropic virus type I.

Authors:  E J Pate; S Z Wiktor; G M Shaw; M E Taylor; E Champegnie; E L Murphy; W A Blattner
Journal:  N Engl J Med       Date:  1991-07-25       Impact factor: 91.245

2.  Antibodies to adult T-cell leukemia-virus-associated antigen (ATLA) in sera from patients with ATL and controls in Japan: a nation-wide sero-epidemiologic study.

Authors:  Y Hinuma; H Komoda; T Chosa; T Kondo; M Kohakura; T Takenaka; M Kikuchi; M Ichimaru; K Yunoki; I Sato; R Matsuo; Y Takiuchi; H Uchino; M Hanaoka
Journal:  Int J Cancer       Date:  1982-06-15       Impact factor: 7.396

3.  The risk of development of HTLV-I-associated myelopathy/tropical spastic paraparesis among persons infected with HTLV-I.

Authors:  J E Kaplan; M Osame; H Kubota; A Igata; H Nishitani; Y Maeda; R F Khabbaz; R S Janssen
Journal:  J Acquir Immune Defic Syndr (1988)       Date:  1990

4.  Primary infection of Japanese infants with adult T-cell leukaemia-associated retrovirus (ATLV): evidence for viral transmission from mothers to children.

Authors:  S Nakano; Y Ando; K Saito; I Moriyama; M Ichijo; T Toyama; K Sugamura; J Imai; Y Hinuma
Journal:  J Infect       Date:  1986-05       Impact factor: 6.072

5.  Monoclonal integration of human T-cell leukemia provirus in all primary tumors of adult T-cell leukemia suggests causative role of human T-cell leukemia virus in the disease.

Authors:  M Yoshida; M Seiki; K Yamaguchi; K Takatsuki
Journal:  Proc Natl Acad Sci U S A       Date:  1984-04       Impact factor: 11.205

6.  A new agglutination test for serum antibodies to adult T-cell leukemia virus.

Authors:  M Ikeda; R Fujino; T Matsui; T Yoshida; H Komoda; J Imai
Journal:  Gan       Date:  1984-10

7.  Mother-to-child transmission of human T-cell leukemia virus type I (HTLV-I): a fifteen-year follow-up study in Okinawa, Japan.

Authors:  K Kusuhara; S Sonoda; K Takahashi; K Tokugawa; J Fukushige; K Ueda
Journal:  Int J Cancer       Date:  1987-12-15       Impact factor: 7.396

8.  Mother-to-child transmission of human T-cell leukemia virus type-I.

Authors:  S Hino; K Yamaguchi; S Katamine; H Sugiyama; T Amagasaki; K Kinoshita; Y Yoshida; H Doi; Y Tsuji; T Miyamoto
Journal:  Jpn J Cancer Res       Date:  1985-06

9.  Identification of HTLV-I sequence in cord blood mononuclear cells of neonates born to HTLV-I antigen/antibody-positive mothers by polymerase chain reaction.

Authors:  S Saito; K Furuki; Y Ando; T Tanigawa; K Kakimoto; I Moriyama; M Ichijo
Journal:  Jpn J Cancer Res       Date:  1990-09

10.  Improvement of gelatin particle agglutination test for detection of anti-HTLV-I antibody.

Authors:  R Fujino; K Kawato; M Ikeda; H Miyakoshi; M Mizukoshi; J Imai
Journal:  Jpn J Cancer Res       Date:  1991-04
View more
  14 in total

1.  Lymphoid organs as a major reservoir for human T-cell leukemia virus type 1 in experimentally infected squirrel monkeys (Saimiri sciureus): provirus expression, persistence, and humoral and cellular immune responses.

Authors:  M Kazanji; A Ureta-Vidal; S Ozden; F Tangy; B de Thoisy; L Fiette; A Talarmin; A Gessain; G de Thé
Journal:  J Virol       Date:  2000-05       Impact factor: 5.103

2.  HTLV-1 targets human placental trophoblasts in seropositive pregnant women.

Authors:  Kenta Tezuka; Naoki Fuchi; Kazu Okuma; Takashi Tsukiyama; Shoko Miura; Yuri Hasegawa; Ai Nagata; Nahoko Komatsu; Hiroo Hasegawa; Daisuke Sasaki; Eita Sasaki; Takuo Mizukami; Madoka Kuramitsu; Sahoko Matsuoka; Katsunori Yanagihara; Kiyonori Miura; Isao Hamaguchi
Journal:  J Clin Invest       Date:  2020-11-02       Impact factor: 14.808

3.  Expression of human T lymphotropic virus type 1 (HTLV-1) tax/rex gene in fresh bronchoalveolar lavage cells of HTLV-1-infected individuals.

Authors:  Y Higashiyama; S Katamine; S Kohno; H Mukae; S Hino; T Miyamoto; K Hara
Journal:  Clin Exp Immunol       Date:  1994-05       Impact factor: 4.330

4.  Immunogenicity and protective efficacy of recombinant human T-cell leukemia/lymphoma virus type 1 NYVAC and naked DNA vaccine candidates in squirrel monkeys (Saimiri sciureus).

Authors:  M Kazanji; J Tartaglia; G Franchini; B de Thoisy; A Talarmin; H Contamin; A Gessain; G de Thé
Journal:  J Virol       Date:  2001-07       Impact factor: 5.103

5.  Up-regulation of human T lymphotropic virus type 1 (HTLV-1) tax/rex mRNA in infected lung tissues.

Authors:  M Seki; Y Higashiyama; A Mizokami; J Kadota; R Moriuchi; S Kohno; Y Suzuki; K Takahashi; T Gojobori; S Katamine
Journal:  Clin Exp Immunol       Date:  2000-06       Impact factor: 4.330

6.  Serological, epidemiological, and molecular differences between human T-cell lymphotropic virus Type 1 (HTLV-1)-seropositive healthy carriers and persons with HTLV-I Gag indeterminate Western blot patterns from the Caribbean.

Authors:  F Rouet; L Meertens; G Courouble; C Herrmann-Storck; R Pabingui; B Chancerel; A Abid; M Strobel; P Mauclere; A Gessain
Journal:  J Clin Microbiol       Date:  2001-04       Impact factor: 5.948

7.  Infection of human synovial cells by human T cell lymphotropic virus type I. Proliferation and granulocyte/macrophage colony-stimulating factor production by synovial cells.

Authors:  M Sakai; K Eguchi; K Terada; M Nakashima; I Yamashita; H Ida; Y Kawabe; T Aoyagi; H Takino; T Nakamura
Journal:  J Clin Invest       Date:  1993-10       Impact factor: 14.808

8.  Association between maternal antibodies to the external envelope glycoprotein and vertical transmission of human T-lymphotropic virus type I. Maternal anti-env antibodies correlate with protection in non-breast-fed children.

Authors:  S Hino; S Katamine; T Miyamoto; H Doi; Y Tsuji; T Yamabe; J E Kaplan; D L Rudolph; R B Lal
Journal:  J Clin Invest       Date:  1995-06       Impact factor: 14.808

9.  Intrauterine transmission of human T-cell leukemia virus type I in rats.

Authors:  M Hori; Y Ami; S Kushida; M Kobayashi; K Uchida; T Abe; M Miwa
Journal:  J Virol       Date:  1995-02       Impact factor: 5.103

10.  Inhibitory activity in saliva of cell-to-cell transmission of human T-cell lymphotropic virus type 1 in vitro: evaluation of saliva as an alternative source of transmission.

Authors:  T Yamamoto; K Terada; N Nishida; R Moriuchi; S Shirabe; T Nakamura; Y Tsuji; T Miyamoto; S Katamine
Journal:  J Clin Microbiol       Date:  1995-06       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.